At the site of injury, nerves release a protein called CXCL12 which attracts growing nerve fibers and keeps them trapped in place. This prevents the nerve fibers from growing in the correct direction to bridge the injury site.
IgA cells that originate in the gut play a role appear to have neuroprotective properties against diseases associated with neuroinflammation, such as meningitis.
By fusing a cytokine to a blood protein, researchers have developed a new therapy to help treat multiple sclerosis.
Identical twins were more likely to have similar sun-seeking behaviors than non-identical twins, suggesting genetics play a key role in sun-seeking behaviors. Researchers identified five genes associated with sun-seeking behavior, some of which have previously been associated with behavioral traits linked to risk-taking and addiction.
Psychological symptoms, such as depression and anxiety, may be a sign COVID-19 is affecting the central nervous system of patients, a new study reports.
Chandelier cells have an unusual direct method of communication. Unlike other neurons, chandelier cells connect directly to the part of a target neuron that initiates a spike.
From losing the sense of taste or smell to developing an increased risk of stroke, researchers investigate both the known and potential long-term implications of COVID-19 infection in the brain.
Reviewing data from past pandemics, researchers suggest some of those exposed to COVID-19 could have an increased risk of developing neurological and mental health disorders in the long term. Acute viral infections can result in encephalopathy, psychosis, depression, demyelination disorders, and problems with neuromuscular function.
Enhancing mitochondrial transportation and cellular energetics could help promote regeneration and function following spinal cord injury.
Dopamine may play a role in activating immune cells to migrate in the early stages of infection.
A global knockout of the thrombin receptor PAR1 accelerates myelin development. The findings could help with the development of treatments for diseases associated with demyelination, like multiple sclerosis.
Intercepting CCL2 with specific antibodies may provide an early intervention for chronic neuropathic pain.
